These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [The role of inflammation in the pathogenesis of atherosclerosis]. Banach M; Markuszewski L; Zasłonka J; Grzegorczyk J; Okoński P; Jegier B Przegl Epidemiol; 2004; 58(4):663-70. PubMed ID: 15810508 [TBL] [Abstract][Full Text] [Related]
4. Arginine and old MACE: small molecules in atherogenesis support the concept of coronary artery disease as a complex trait. Levin RI J Am Coll Cardiol; 2009 Jun; 53(22):2068-9. PubMed ID: 19477357 [No Abstract] [Full Text] [Related]
5. Does gender modify the detrimental coronary effects of metabolic syndrome? Turhan H; Yetkin E; Kose S; Isik E Int J Cardiol; 2006 Jun; 110(2):261-2. PubMed ID: 16249040 [TBL] [Abstract][Full Text] [Related]
6. Insights into the role of infection in atherogenesis and in plaque rupture. Epstein SE; Zhu J; Najafi AH; Burnett MS Circulation; 2009 Jun; 119(24):3133-41. PubMed ID: 19546396 [No Abstract] [Full Text] [Related]
7. Homocysteine and coronary heart disease: a review of the current evidence. Pasceri V; Willerson JT Semin Interv Cardiol; 1999 Sep; 4(3):121-8. PubMed ID: 10545618 [TBL] [Abstract][Full Text] [Related]
9. Hyperhomocysteinemia in patients with coronary artery disease. Mahanonda N; Leowatana W; Bhuripanyo K; Samranthin M; Kangkagate C J Med Assoc Thai; 2000 Nov; 83(11):1354-60. PubMed ID: 11215866 [TBL] [Abstract][Full Text] [Related]
10. [The role of free radicals in coronary atherosclerosis]. Puddu P G Ital Cardiol; 1998 Nov; 28(11):1200-6. PubMed ID: 9866796 [No Abstract] [Full Text] [Related]
12. [Expression of urotensinII in human coronary artery and coronary atherosclerosis]. Tu XW; Liu YF; Li ZL; Wu HC; Lu Q; Tang CS Di Yi Jun Yi Da Xue Xue Bao; 2003 Jun; 23(6):572-4. PubMed ID: 12810379 [TBL] [Abstract][Full Text] [Related]
13. High-sensitivity C-reactive protein may be an indicator of the development of atherosclerosis in myocardial bridging. Duygu H; Zoghi M; Nalbantgil S; Ozerkan F; Cakir C; Ertas F; Yuksek U; Akilli A; Akin M; Ergene O Int J Cardiol; 2008 Feb; 124(2):267-70. PubMed ID: 17395309 [TBL] [Abstract][Full Text] [Related]
14. Oxidised low density lipoprotein, antioxidants and coronary atherosclerosis. Gambhir DS; Gambhir JK Indian Heart J; 1997; 49(1):19-22. PubMed ID: 9130420 [No Abstract] [Full Text] [Related]
15. [IGF-1--a new risk factor for coronary atherosclerosis]. Burchardt P; Goździcka-Józefiak A; Siminiak T Kardiol Pol; 2006 Nov; 64(11):1297-302. PubMed ID: 17165168 [No Abstract] [Full Text] [Related]
16. The search for the "holy grail" of clinically significant coronary atherosclerosis. Ewy GA Arch Intern Med; 2004 Jun; 164(12):1266-8. PubMed ID: 15226158 [No Abstract] [Full Text] [Related]
18. Oxidative stress, endothelial function and coronary atherosclerosis. Anderson TJ Cardiologia; 1997 Jul; 42(7):701-14. PubMed ID: 9270179 [No Abstract] [Full Text] [Related]
19. Cardiovascular disease. Does inflammation cut to the heart of the matter? Taubes G Science; 2002 Apr; 296(5566):242-5. PubMed ID: 11951014 [No Abstract] [Full Text] [Related]